Zobrazeno 1 - 10 of 13 pro vyhledávání: '"Shaun Peterson"'
1
Abstract 4251: A performance characterization of microsatellite instability and mismatch repair testing methods in endometrial samples
Autor: Heather Tomlinson, Samantha R. Lewis, Kathryn Oostdik, Shaun Peterson
Publikováno v: Cancer Research. 80:4251-4251
Microsatellite instability (MSI), a functional measure of mismatch repair (MMR) deficiency, and immunohistochemistry testing for MMR proteins are well established technologies traditionally used for Lynch Syndrome screening in colorectal cancer. Rece
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d81ce31e3be9348323762be0e0949dc2
https://doi.org/10.1158/1538-7445.am2020-4251
Zobrazit plný text záznamu
2
VIEW FROM A REAL INDIAN
Autor: SHAUN PETERSON
Publikováno v: Identity, Tradition and Revitalisation of American Indian Culture ISBN: 9788024635859
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ac46c379f060ba4cc287a71b901efc69
https://doi.org/10.2307/jj.1544752.14
Zobrazit plný text záznamu
3
Abstract 2563: A comparison of microsatellite instability analysis methods for detection of mismatch repair deficiency
Autor: Samantha R. Lewis, Shaun Peterson, Kathryn Oostdik, Heather Tomlinson
Publikováno v: Cancer Research. 79:2563-2563
Use of biomarkers for patient treatment stratification is an increasingly important topic with the recent FDA approval of Pembrolizumab and Nivolumab for microsatellite instability (MSI) high/mismatch repair (MMR) deficient cancers. This ground-break
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::38a41071eec4806cfaa0b2de0ac56737
https://doi.org/10.1158/1538-7445.am2019-2563
Zobrazit plný text záznamu
4
A comparison of microsatellite instability analysis methods in colorectal cancer
Autor: Kathryn Oostdik, Heather Tomlinson, Samantha R. Lewis, Shaun Peterson
Publikováno v: Journal of Clinical Oncology. 37:46-46
46 Background: Use of biomarkers for patient treatment stratification is an increasingly important topic with the recent FDA approval of Pembrolizumab and Nivolumab for microsatellite instability (MSI) high/mismatch repair (MMR) deficient cancers. Th
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9721293effb3ca053b3e47726b53ad5d
https://doi.org/10.1200/jco.2019.37.8_suppl.46
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje